BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10986617)

  • 1. Biochemical markers of bone formation.
    Gundberg CM
    Clin Lab Med; 2000 Sep; 20(3):489-501. PubMed ID: 10986617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of bone turnover: an update.
    van Daele PL; Birkenhäger JC; Pols HA
    Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers of bone turnover.
    Rosalki SB
    Int J Clin Pract; 1998 Jun; 52(4):255-6. PubMed ID: 9744151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone markers: biochemical and clinical significance.
    Lello S; Paoletti AM; Migliaccio S; Melis GB
    Aging Clin Exp Res; 2004 Jun; 16 Suppl(3):33-6. PubMed ID: 15506699
    [No Abstract]   [Full Text] [Related]  

  • 6. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
    Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
    Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone markers in osteoporosis and malignancy.
    Lipton A; Costa L; Demers LM
    Can J Oncol; 1995 Dec; 5 Suppl 1():11-5. PubMed ID: 8853519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of bone health and osteoporosis risk.
    Eastell R; Hannon RA
    Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical markers of bone remodeling].
    Briot K; Roux C
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1009-13. PubMed ID: 16316769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
    Koizumi M; Yonese J; Fukui I; Ogata E
    J Urol; 2002 Apr; 167(4):1863-6. PubMed ID: 11912449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of bone metabolism in growing thoroughbreds: a longitudinal study.
    Price JS; Jackson BF; Gray JA; Harris PA; Wright IM; Pfeiffer DU; Robins SP; Eastell R; Ricketts SW
    Res Vet Sci; 2001 Aug; 71(1):37-44. PubMed ID: 11666146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.
    Löfman O; Magnusson P; Toss G; Larsson L
    Clin Chim Acta; 2005 Jun; 356(1-2):67-75. PubMed ID: 15936304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers].
    Miura M
    Clin Calcium; 2009 Aug; 19(8):1160-9. PubMed ID: 19638700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.
    Reginster JY; Sarkar S; Zegels B; Henrotin Y; Bruyere O; Agnusdei D; Collette J
    Bone; 2004 Feb; 34(2):344-51. PubMed ID: 14962813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis.
    Honjo S; Mizunuma H
    Am J Obstet Gynecol; 2001 Jul; 185(1):246-7. PubMed ID: 11483939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.